We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

99 hedge funds and large institutions have $657M invested in GenMark Diagnostics, Inc in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 13

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

15% more funds holding

Funds holding: 86 → 99 (+13)

6% more capital invested

Capital invested by funds: $618M → $657M (+$39.6M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
99
Holders Change
+13
Holders Change %
+15.12%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
50
Reduced
13
Closed
6
Calls
$58K
Puts
–
Net Calls
+$58K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$12.2M
3
CCM
Cadian Capital Management
New York
+$10.2M
4
JP Morgan Chase
JP Morgan Chase
New York
+$7.15M
5
MWNA
Marshall Wace North America
New York
+$6.59M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.31M
2
CRC
Curi RMB Capital
Illinois
-$6.41M
3
Morgan Stanley
Morgan Stanley
New York
-$4.02M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.1M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$536K
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$4.87M +$1.11M +86,600 +27%
BG
27
Bellevue Group
Switzerland
$4.79M +$1.18M +92,512 +30%
Wells Fargo
28
Wells Fargo
California
$3.58M +$3.3M +258,040 +576%
CRC
29
Curi RMB Capital
Illinois
$3.56M -$6.41M -501,372 -63%
Allianz Asset Management
30
Allianz Asset Management
Germany
$3.2M +$241K +18,842 +7%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$3.01M +$791K +61,841 +32%
Charles Schwab
32
Charles Schwab
California
$2.68M -$124K -9,730 -4%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.64M +$233K +18,235 +9%
Point72 Asset Management
34
Point72 Asset Management
Connecticut
$2.38M +$2.57M +201,000 New
Federated Hermes
35
Federated Hermes
Pennsylvania
$2.37M +$2.55M +199,683 +62,991%
Deutsche Bank
36
Deutsche Bank
Germany
$2.31M +$222K +17,401 +10%
TCIM
37
TIAA CREF Investment Management
New York
$2M +$16.2K +1,268 +0.8%
MIM
38
Monashee Investment Management
Massachusetts
$1.48M +$1.6M +125,000 New
TD Asset Management
39
TD Asset Management
Ontario, Canada
$1.35M +$158K +12,394 +12%
TA
40
Teachers Advisors
New York
$1.29M -$29.5K -2,309 -2%
TCM
41
Tekla Capital Management
Massachusetts
$1.1M – – –
WMSA
42
Weiss Multi-Strategy Advisers
New York
$1.08M +$268K +21,000 +30%
Swiss National Bank
43
Swiss National Bank
Switzerland
$1.05M +$309K +24,200 +37%
MS
44
Maven Securities
Jersey
$947K +$1.02M +80,000 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$920K -$102K -8,000 -9%
Goldman Sachs
46
Goldman Sachs
New York
$816K +$37.6K +2,945 +4%
DCM
47
Donaldson Capital Management
Indiana
$786K – – –
Tudor Investment Corp
48
Tudor Investment Corp
Connecticut
$741K +$801K +62,652 New
Invesco
49
Invesco
Georgia
$721K +$779K +60,919 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$628K – – –
1
2
3 4 5

GNMK Hedge Fund Activity: Q2 2017 in Review

99 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2017, worth a combined $657M — up 6.4% from $618M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new GNMK positions and 6 closed out — a net gain of 13 holders — while 50 added to existing stakes and 13 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $12.3M. The largest seller was Adage Capital Partners, cutting an estimated $8.31M.

  • 99 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2017, up from 86 in Q1 2017.
  • Funds reported $657M of GenMark Diagnostics, Inc stock for Q2 2017, up 6.4% quarter-over-quarter.
  • 19 funds opened new GenMark Diagnostics, Inc positions in Q2 2017 and 6 closed out, a net change of +13 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q2 2017 was Fidelity Investments, an estimated $12.3M added.
  • The largest GenMark Diagnostics, Inc seller in Q2 2017 was Adage Capital Partners, an estimated $8.31M sold.

Based on aggregated 13F filings for Q2 2017.